Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis

BACKGROUND: Dipeptidyl peptidase 4 (DPP4) is a serine exopeptidase able to inactivate various oligopeptides, and also a hepatokine. Hepatocyte-specific overexpression of DPP4 is associated with hepatic insulin resistance and liver steatosis. METHOD: We examined whether weekly DPP4 inhibitor omarigli...

Descripción completa

Detalles Bibliográficos
Autores principales: Hattori, Sachiko, Nomoto, Kazuomi, Suzuki, Tomohiko, Hayashi, Seishu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7945344/
https://www.ncbi.nlm.nih.gov/pubmed/33691757
http://dx.doi.org/10.1186/s13098-021-00644-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7945344/
https://www.ncbi.nlm.nih.gov/pubmed/33691757
http://dx.doi.org/10.1186/s13098-021-00644-5

Ejemplares similares